发明名称 Recombinant interferon alpha 2 (IFN alpha 2) mutants
摘要 <p>The present invention provides IFN±2 mutants and active fragments, analogs, derivatives, and variants thereof that have improved specific agonist or antagonist activity as compared to wild-type IFN±2. The present invention further provides pharmaceutical compositions comprising IFN±2 mutants useful for treating or preventing cancer, autoimmune diseases, infectious diseases or disorders associated with increased expression of IFN±2.</p>
申请公布号 EP2476428(B1) 申请公布日期 2013.08.21
申请号 EP20120154308 申请日期 2006.06.28
申请人 YEDA RESEARCH AND DEVELOPMENT CO. LTD. 发明人 SCHREIBER, GIDEON;ROISMAN, LAILA C.;JAITIN, DIEGO;KALIE, EYAL
分类号 A61K38/21 主分类号 A61K38/21
代理机构 代理人
主权项
地址